Reaction
Blood Triglycerides Abnormal reporting signals
As of the last recalculation, Blood Triglycerides Abnormal appears in 866 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ICOSAPENT ETHYL (PRR 84.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Icosapent Ethyl | 29 | 84.7 | 85.0 |
| Inclisiran | 11 | 33.4 | 33.4 |
| Gemfibrozil | 14 | 22.5 | 22.5 |
| Fenofibrate | 31 | 21.8 | 21.8 |
| Nevirapine | 8 | 21.5 | 21.5 |
| Zidovudine | 8 | 14.5 | 14.5 |
| Lamivudine Oral | 14 | 13.5 | 13.5 |
| Isotretinoin | 24 | 12.0 | 12.0 |
| Relugolix | 10 | 10.3 | 10.3 |
| Evolocumab | 47 | 7.3 | 7.3 |
| Alirocumab | 6 | 5.8 | 5.8 |